Canwen Jiang
About Canwen Jiang
Canwen Jiang serves as the Chief Development Officer and Chief Medical Officer at Asklepios BioPharmaceutical, Inc. He has extensive experience in clinical development and research, having held key positions at various pharmaceutical companies and academic institutions.
Work at Asklepios BioPharmaceutical
Canwen Jiang currently serves as the Chief Development Officer and Chief Medical Officer at Asklepios BioPharmaceutical, Inc. (AskBio), a position he has held since 2021. His role involves overseeing the development of innovative therapies and advancing the company's pipeline in various therapeutic areas. Jiang previously worked at AskBio in 2020 as Chief Development Officer for a period of four months.
Education and Expertise
Canwen Jiang holds a Doctor of Philosophy (Ph.D.) in Cardiology from Imperial College London and a Doctor of Medicine (M.D.) from Hunan College of Medicine and Hunan College of Chinese Medicine. His education provides a strong foundation for his extensive career in medical and clinical development. Jiang possesses in-depth knowledge of regulatory frameworks and ICH-GCP guidelines, along with expertise in multiple technology platforms, including recombinant proteins, antibodies, gene and cell therapy, small molecules, and medical devices.
Background
Canwen Jiang has a diverse background in the pharmaceutical and biotechnology industries. He began his career in clinical cardiology at Royal Brompton and Harefield hospitals in London. He has held various roles in prominent organizations, including Sanofi Genzyme, Novartis, and Ring Therapeutics. His experience spans several therapeutic areas, including genetic/rare disorders, ophthalmology, cardiovascular/metabolism, oncology/hematology, infectious diseases, central nervous system, and gastrointestinal disorders.
Achievements
Throughout his career, Canwen Jiang has built and led world-class development and medical organizations. He served as Global Head of Clinical Development for the Alcon Division at Novartis and held the position of Global Therapeutic Area Head for Ophthalmology & ENT at Novartis Global Drug Development. Jiang's leadership roles have contributed to advancing pipelines in various therapeutic areas, showcasing his ability to drive innovation in the pharmaceutical sector.
Previous Positions
Canwen Jiang has held several significant positions prior to his current role. He worked as Global Vice President and Head of R&D Asia at Sanofi Genzyme from 2005 to 2011 and was a Co-Founder and CEO at Sinovant Sciences from 2018 to 2019. Additionally, he has experience as a Member of the Scientific Advisory Board at Ring Therapeutics and as Chief Medical Officer at Laronde.bio, demonstrating his extensive involvement in the industry.